Saturday, June 13, 2009

Methylprednisolone plus IFN beta and relapsing-remitting MS: the NORMIMS study | News | MS Trust - Information, education, research and support

World map showing that risk (incidence) for MS...Image via Wikipedia

Methylprednisolone plus IFN beta and relapsing-remitting MS: the NORMIMS study | News | MS Trust - Information, education, research and support: "Adding oral methylprednisolone (MP) to the standard treatment of subcutaneous interferon beta-1a (IFNb-1a) substantially reduces the relapse rate in patients with relapsing-remitting multiple sclerosis (RRMS), according to a study published early online and appearing in the June"
Reblog this post [with Zemanta]
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)